111 related articles for article (PubMed ID: 3059738)
1. Hereditary pituitary prolactinomas: a new rat model.
Chedid A; Hoversland RC; Chejfec G; McCune SA; Jurin RR; Evans EE
Acta Endocrinol (Copenh); 1988 Dec; 119(4):535-42. PubMed ID: 3059738
[TBL] [Abstract][Full Text] [Related]
2. Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link?
Perić B; Kruljac I; Šundalić S; Pećina HI; Jović A; Štefanović M; Butorac D; Vrkljan M
Endocr Res; 2016 Aug; 41(3):200-6. PubMed ID: 26864960
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
Ma W; Ikeda H; Yoshimoto T
Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
[TBL] [Abstract][Full Text] [Related]
4. Comparative immunohistochemical analysis of estrogen receptor and chromogranin-A reactivity in plurihormonal human prolactinomas.
Talan-Hranilović J; Gnjidić Z; Sajko T; Vizner B; Vrkljan M
Acta Med Croatica; 2000; 54(2):59-63. PubMed ID: 11028110
[TBL] [Abstract][Full Text] [Related]
5. Correlations between presence of spontaneous lesions of the pituitary (adenohypophysis) and plasma prolactin concentration in aged Wistar rats.
van Nesselrooij JH; Kuper CF; Bosland MC
Vet Pathol; 1992 Jul; 29(4):288-300. PubMed ID: 1325082
[TBL] [Abstract][Full Text] [Related]
6. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].
Gao L; Yang QH; Xu RK
Sheng Li Xue Bao; 2005 Jun; 57(3):319-27. PubMed ID: 15968426
[TBL] [Abstract][Full Text] [Related]
7. Women with prolactin-producing pituitary adenoma show decreased serum placental lactogen during pregnancy.
Luthman M; Bremme K; Eneroth P; Werner S
Gynecol Obstet Invest; 1993; 35(2):80-5. PubMed ID: 8449449
[TBL] [Abstract][Full Text] [Related]
8. Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats.
Carretero J; Burks DJ; Vázquez G; Rubio M; Hernández E; Bodego P; Vázquez R
Pituitary; 2002 Jan; 5(1):5-10. PubMed ID: 12638719
[TBL] [Abstract][Full Text] [Related]
9. Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levels.
Ahtiainen P; Sharp V; Rulli SB; Rivero-Müller A; Mamaeva V; Röyttä M; Huhtaniemi I
Endocr Relat Cancer; 2010 Sep; 17(3):611-21. PubMed ID: 20453081
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenomas in old Sprague-Dawley rats: a histologic, ultrastructural, and immunocytochemical study.
McComb DJ; Kovacs K; Beri J; Zak F
J Natl Cancer Inst; 1984 Nov; 73(5):1143-66. PubMed ID: 6092768
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of different mutations in regulatory sequence of prolactin gene during the formation of 17 beta-estradiol-induced prolactinoma in eutopic and ectopic pituitary of rats].
Zhang FZ; Yang QH; Mao YC; Xu RK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):822-7. PubMed ID: 17260475
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine.
Osamura RY; Watanabe K
Acta Pathol Jpn; 1986 Aug; 36(8):1131-7. PubMed ID: 3776530
[TBL] [Abstract][Full Text] [Related]
13. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
[TBL] [Abstract][Full Text] [Related]
14. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
Saitoh Y; Koizumi K; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Anticancer Res; 1986; 6(5):1149-55. PubMed ID: 3800323
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effects of melatonin on the development of 17-beta-estradiol induced prolactinoma in relation to plasma prolactin and peroxidative lipid contents].
Gao L; Xu JP; Shan HM; Zhang R; Xu RK
Sheng Li Xue Bao; 2001 Jun; 53(3):165-9. PubMed ID: 12589398
[TBL] [Abstract][Full Text] [Related]
17. Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.
Cao L; Gao H; Gui S; Bai G; Lu R; Wang F; Zhang Y
J Neurooncol; 2014 Feb; 116(3):523-31. PubMed ID: 24407733
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of miR-193a-3p in invasive pituitary adenomas.
Su WJ; Wang JS; Ye MD; Chen WL; Liao CX
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7673-7680. PubMed ID: 32744693
[TBL] [Abstract][Full Text] [Related]
19. [Morphological studies on estrogen-induced PRL cell hyperplasia in rat pituitary gland--immunocytochemical and scanning electron microscopic studies].
Inagaki H; Hori T
No To Shinkei; 1989 Jun; 41(6):593-601. PubMed ID: 2803826
[TBL] [Abstract][Full Text] [Related]
20. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
